Q32 Bio Inc. (QTTB) Non Operating Income (2023 - 2026)

Q32 Bio has reported Non Operating Income for 4 years, with the latest figure at $172000.0 in Q2 2026.

• On a quarterly basis, Non Operating Income rose 154.09% year-over-year to $172000.0 in Q2 2026; TTM through Jun 2026 was $12.3 million, a 401.79% increase from a year earlier, with the FY2025 full-year figure at $12.9 million, down 35.45% from the prior year.
• Non Operating Income was $172000.0 for Q2 2026 at Q32 Bio, up from $113000.0 in the prior quarter.
• The five-year high for Non Operating Income was $16.0 million in Q1 2024, with the low at -$6.2 million in Q3 2023.
• Average Non Operating Income over 4 years is $2.0 million, with a median of $446500.0 recorded in 2023.
• The largest YoY upside for Non Operating Income was 3210.34% in 2025 against a maximum downside of 113.31% in 2025.
• Over 4 years, Non Operating Income stood at -$1.0 million in 2023, then jumped by 135.62% to $358000.0 in 2024, then jumped by 3210.34% to $11.9 million in 2025, then sank by 98.55% to $172000.0 in 2026.
• The last three Non Operating Income figures came in at $172000.0 (Q2 2026), $113000.0 (Q1 2026), and $11.9 million (Q4 2025), per Business Quant data.